News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,628 Results
Type
Article (55435)
Company Profile (323)
Press Release (705870)
Multimedia
Podcasts (91)
Webinars (13)
Section
Business (216158)
Career Advice (2379)
Deals (37175)
Drug Delivery (122)
Drug Development (87964)
Employer Resources (178)
FDA (17258)
Job Trends (16068)
News (368877)
Policy (36173)
Tag
Academia (2922)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (95)
Alliances (53248)
ALS (106)
Alzheimer's disease (1494)
Antibody-drug conjugate (ADC) (157)
Approvals (17218)
Artificial intelligence (306)
Autoimmune disease (28)
Automation (17)
Bankruptcy (382)
Best Places to Work (12439)
BIOSECURE Act (21)
Biosimilars (120)
Biotechnology (211)
Bladder cancer (86)
Brain cancer (31)
Breast cancer (309)
Cancer (2470)
Cardiovascular disease (211)
Career advice (2001)
Career pathing (30)
CAR-T (174)
Cell therapy (478)
Cervical cancer (22)
Clinical research (71451)
Collaboration (931)
Company closure (2)
Compensation (584)
Complete response letters (29)
COVID-19 (2846)
CRISPR (49)
C-suite (267)
Cystic fibrosis (109)
Data (2375)
Decentralized trials (2)
Denatured (31)
Depression (55)
Diabetes (299)
Diagnostics (6818)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (127)
Drug pricing (130)
Drug shortages (31)
Duchenne muscular dystrophy (104)
Earnings (89689)
Editorial (47)
Employer branding (22)
Employer resources (152)
Events (123227)
Executive appointments (782)
FDA (18689)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (820)
Gene editing (124)
Generative AI (30)
Gene therapy (353)
GLP-1 (837)
Government (5083)
Grass and pollen (6)
Guidances (158)
Healthcare (20563)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (153)
Indications (30)
Infectious disease (3010)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (403)
IPO (17070)
IRA (48)
Job creations (4066)
Job search strategy (1684)
Kidney cancer (11)
Labor market (43)
Layoffs (539)
Leadership (17)
Legal (8812)
Liver cancer (82)
Lung cancer (350)
Lymphoma (162)
Machine learning (9)
Management (62)
Manufacturing (354)
MASH (84)
Medical device (14216)
Medtech (14221)
Mergers & acquisitions (20689)
Metabolic disorders (792)
Multiple sclerosis (90)
NASH (22)
Neurodegenerative disease (118)
Neuropsychiatric disorders (33)
Neuroscience (2114)
NextGen: Class of 2025 (7234)
Non-profit (4998)
Now hiring (40)
Obesity (426)
Opinion (255)
Ovarian cancer (84)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (163)
Partnered (22)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (61257)
Pharmaceutical (75)
Pharmacy benefit managers (21)
Phase I (22232)
Phase II (31276)
Phase III (23488)
Pipeline (1419)
Policy (173)
Postmarket research (2963)
Preclinical (9447)
Press Release (72)
Prostate cancer (115)
Psychedelics (37)
Radiopharmaceuticals (266)
Rare diseases (435)
Real estate (6503)
Recruiting (66)
Regulatory (24623)
Reports (47)
Research institute (2601)
Resumes & cover letters (388)
Rett syndrome (6)
RNA editing (5)
RSV (50)
Schizophrenia (84)
Series A (140)
Series B (94)
Service/supplier (20)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (161)
Sponsored (33)
Startups (3917)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (54)
The Weekly (58)
Vaccines (816)
Venture capitalists (44)
Weight loss (291)
Women's health (40)
Worklife (19)
Date
Today (184)
Last 7 days (1009)
Last 30 days (3248)
Last 365 days (34283)
2025 (12548)
2024 (37085)
2023 (41982)
2022 (53309)
2021 (58022)
2020 (56936)
2019 (50405)
2018 (38326)
2017 (34702)
2016 (34864)
2015 (40817)
2014 (34628)
2013 (29812)
2012 (31981)
2011 (32577)
2010 (31009)
Location
Africa (928)
Alabama (58)
Alaska (7)
Arizona (255)
Arkansas (14)
Asia (42862)
Australia (7324)
California (6574)
Canada (2102)
China (572)
Colorado (283)
Connecticut (301)
Delaware (167)
Europe (94815)
Florida (982)
Georgia (229)
Hawaii (1)
Idaho (64)
Illinois (594)
India (27)
Indiana (341)
Iowa (11)
Japan (175)
Kansas (110)
Kentucky (27)
Louisiana (13)
Maine (71)
Maryland (974)
Massachusetts (4985)
Michigan (250)
Minnesota (426)
Mississippi (2)
Missouri (86)
Montana (31)
Nebraska (25)
Nevada (70)
New Hampshire (68)
New Jersey (1859)
New Mexico (29)
New York (1865)
North Carolina (1104)
North Dakota (8)
Northern California (2871)
Ohio (223)
Oklahoma (15)
Oregon (40)
Pennsylvania (1461)
Puerto Rico (14)
Rhode Island (33)
South America (1291)
South Carolina (26)
South Dakota (1)
Southern California (2472)
Tennessee (107)
Texas (979)
United States (25048)
Utah (198)
Virginia (161)
Washington D.C. (70)
Washington State (587)
West Virginia (3)
Wisconsin (66)
761,628 Results for "tri anim health services inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
FDA To Replace Some Animal Testing With AI, Human ‘Organoid’ Lab Models
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their investigational products. Though the process to phase out animal testing will begin “immediately,” no specific timetable was given.
April 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan
April 2, 2025
·
3 min read
Press Releases
Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
March 5, 2025
·
5 min read
Pharm Country
Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD
Tris Pharma, Inc. has entered into a licensing agreement with Braingaze Ltd. and launched its new business, Tris Digital Health, which will focus on the development and commercialization of digital diagnostic and therapeutic products for neurological health conditions.
April 16, 2024
·
5 min read
Press Releases
BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
May 2, 2025
·
23 min read
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs
April 28, 2025
·
11 min read
Policy
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.
June 25, 2024
·
6 min read
Press Releases
Nona Biosciences Announces Strategic Collaboration with Invetx for Next-Generation Animal Health Biotherapeutics Discovery
February 3, 2025
·
2 min read
Press Releases
Tris Pharma to Unveil Positive Phase 3 Results including a Strong Safety Profile Showcasing the Potential of Cebranopadol, an Investigational First-in-Class Dual-NMR Agonist for the Treatment of Pain, at the 2025 ASRA Annual Meeting
May 1, 2025
·
5 min read
1 of 76,163
Next
